Emad Mikhail, MD
Interventional Pain Medicine · Willoughby Hills, OHNPI 1790757375
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.8%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Boston Scientific at 57.4% of the total. Reporting peaked in 2019 at $2,150 and has fallen 82.3% since, to $380 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.
Across 24 payments — averaging $143.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$387
- Globus Medical$350
- Nevro Corp.$272
- Si-bone, Inc.$103
- Abbott$94
- plus $263 from 5 others
What the payments were for
- Grants$1625%
- Travel & lodging$1,55545%
- Food & beverage$1,71950%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $1,980 |
| Medtronic(2 entities) | 4 | $387 |
| Globus Medical | 3 | $350 |
| Nevro Corp. | 3 | $272 |
| Si-bone, Inc. | 2 | $103 |
| Abbott | 1 | $94 |
| Averitas Pharma Inc. | 1 | $87 |
| Pfizer | 1 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $70 |
| Johnson & Johnson | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$1,750
- Senza$301
- INTELLIS ADAPTIVESTIM$162
- Omnia$124
- Senza Spinal Cord Stimulation System$106
- INTELLIS$102
How this compares
$3,449 in reported general payments places this provider in the 40th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 71 | $19,937 |
| Pregabalin | 312 | $9,979 |
| Gabapentin | 692 | $7,334 |
| OxycontinOxycodone Hcl | 38 | $6,989 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 495 | $3,798 |
| Hydromorphone ErHydromorphone Hcl | 18 | $3,679 |
| Fentanyl | 34 | $2,863 |
| Lidocaine | 27 | $1,991 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 193 | $1,702 |
| Buprenorphine | 12 | $1,359 |
| Methocarbamol | 95 | $1,219 |
| Duloxetine Hcl | 95 | $932 |
| Tramadol Hcl | 279 | $883 |
| Cyclobenzaprine Hcl | 117 | $800 |
| Tizanidine Hcl | 124 | $764 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Willoughby Hills
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
- David WalegaColumbus$37K
- Ronald LinehanLancaster$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.